Netherlands vs Switzerland: Share of S. aureus infections resistant to methicillin
Netherlands
2.3%
in 2022
Switzerland
4.1%
in 2022
Netherlands rank
42nd
Switzerland rank
39th
Share of S. aureus infections resistant to methicillin over time
- Netherlands
- Switzerland
How they compare
Switzerland currently reports 4.1% against 2.3% in Netherlands, a difference of 1.8%.
That makes Switzerland's figure about 1.8 times Netherlands's.
Across all 6 years both countries report, Switzerland has been ahead every year.
Netherlands ranks 42nd and Switzerland ranks 39th of 45 countries.
Switzerland has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Netherlands | Switzerland | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.4% | 4.8% | 3.4% | Switzerland |
| 2020s | 1.8% | 11.1% | 9.3% | Switzerland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of s. aureus infections resistant to methicillin, Netherlands or Switzerland?
- Switzerland, at 4.1% against 2.3% in Netherlands as of 2022.
- What is the difference in share of s. aureus infections resistant to methicillin between Netherlands and Switzerland?
- 1.8%, with Switzerland ahead.
- How many years of comparable data are there for Netherlands and Switzerland?
- 6 years are reported by both, from 2017 to 2022.
- How do Netherlands and Switzerland rank globally for share of s. aureus infections resistant to methicillin?
- Netherlands ranks 42nd and Switzerland ranks 39th of 45 countries.
- Where does this data come from?
- World Health Organization – processed by Our World in Data, published as Share of S. aureus infections resistant to methicillin. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested (%).